NTLA R&D Expenses
Intellia Therapeutics Inc · R&D Expenses
NTLA R&D Expenses
Latest reported$346.73Mperiod ending
NTLA TTM R&D Expenses ($11.17M → $346.73M)
TTM R&D Expenses
High-resolution chart · PNG
NTLA r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 346,731,000 | |
| 361,171,000 | |
| 388,861,000 | |
| 417,086,000 | |
| 445,719,000 | |
| 460,292,000 | |
| 461,200,000 | |
| 453,304,000 | |
| 443,620,000 | |
| 447,288,000 | |
| 435,069,000 | |
| 426,122,000 | |
| 409,077,000 | |
| 384,000,000 | |
| 419,979,000 | |
| 391,106,000 | |
| 354,941,000 | |
| 323,626,000 | |
| 229,807,000 | |
| 196,877,000 | |
| 176,147,000 | |
| 155,034,000 | |
| 150,408,000 | |
| 143,908,000 | |
| 131,665,000 | |
| 119,354,000 | |
| 108,413,000 | |
| 96,600,000 | |
| 92,324,000 | |
| 90,331,000 | |
| 89,115,000 | |
| 90,367,000 | |
| 84,611,000 | |
| 76,709,000 | |
| 67,647,000 | |
| 57,808,000 | |
| 48,188,000 | |
| 40,046,000 | |
| 31,840,000 | |
| 24,884,000 | |
| 20,481,000 | |
| 15,024,000 | |
| 11,170,000 | |
| 11,297,000 | |
| 7,850,000 |